Viewing nowJ-Basujeong 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

MFDS item code 201707147 · Approved 2017.09.19
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication helps patients with primary hypercholesterolemia or mixed dyslipidemia, and familial hypercholesterolemia who cannot control their conditions through diet and exercise. It lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia and slows the progression of atherosclerosis. It is also used in children aged 10 to 17 years with severe hypercholesterolemia to manage blood lipid levels. Additionally, it serves as an adjunct to diet in patients with primary dysbetalipoproteinemia. In middle-aged patients with elevated high-sensitivity C-reactive protein and risk factors for cardiovascular disease, it helps reduce risks associated with stroke, myocardial infarction, and vascular interventions. Overall, this medication effectively improves the management of dyslipidemia and cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response, up to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is needed. 4. Patients with renal impairment: No dose adjustment is needed in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, individuals with allergies to any ingredient of this medication, severely impaired liver function, muscle disorders, and women who are pregnant or breastfeeding should not take this medication. Additionally, patients with severely impaired kidney function or those taking specific medications need to use caution. This medication can affect liver health, so individuals with a history of liver disease or those who consume alcohol heavily should have liver function tests done before and during treatment. If symptoms such as muscle pain or weakness occur, the doctor should be informed immediately, and in severe cases, the medication might need to be discontinued. This medication may increase blood sugar levels in some patients, so those at risk for diabetes should strictly manage their blood sugar levels. Furthermore, there may be interactions when taken with other medications, especially certain antivirals, immunosuppressants, or lipid-lowering agents. Women who are pregnant or may become pregnant must use appropriate contraception and should discontinue the medication immediately if pregnancy is confirmed. In the case of overdose, since there is no specific antidote, symptomatic treatment should be provided, and liver function and muscle enzyme levels should be monitored. Lastly, this medication can rarely cause serious skin reactions, liver damage, or muscle disorders, so any unusual symptoms should prompt immediate consultation with medical personnel.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced eosinophilic dermatitis, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, systemic pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to protect it from air and moisture. It should also be stored at a temperature between 1 and 30 degrees Celsius.
Pink round film-coated tablets
30 tablets/box [(10 tablets/Alu-Alu X 3)], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.